Detalhe da pesquisa
1.
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
Prostate
; 84(5): 473-478, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38149793
2.
Other-cause mortality in incidental prostate cancer.
Prostate
; 84(8): 731-737, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506561
3.
Race has no impact on prostate cancer-specific mortality, when comparing patients with similar risk of other-cause mortality: An analysis of a population-based cohort.
Cancer
; 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38804713
4.
Perioperative Complications and In-Hospital Mortality in Partial and Radical Nephrectomy Patients with Heart-Valve Replacement.
Ann Surg Oncol
; 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38526833
5.
Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma.
Ann Surg Oncol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773038
6.
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial.
Eur J Nucl Med Mol Imaging
; 51(3): 907-918, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897615
7.
Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis.
BJU Int
; 133(5): 555-563, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097533
8.
Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer.
BJU Int
; 133(2): 214-222, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37803523
9.
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.
BJU Int
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621771
10.
Trimodal therapy effect on survival in urothelial vs non-urothelial bladder cancer.
BJU Int
; 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494989
11.
Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment.
J Natl Compr Canc Netw
; : 1-7, 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38838708
12.
Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysis.
World J Urol
; 42(1): 251, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652316
13.
Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral center.
World J Urol
; 42(1): 270, 2024 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679650
14.
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus.
World J Urol
; 42(1): 264, 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38676733
15.
Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients.
World J Urol
; 42(1): 343, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775841
16.
Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
World J Urol
; 42(1): 269, 2024 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679642
17.
Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy.
World J Urol
; 42(1): 193, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530480
18.
Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging.
Curr Opin Urol
; 34(4): 294-299, 2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587018
19.
Contemporary conditional cancer-specific survival rates in surgically treated nonmetastatic primary urethral carcinoma.
J Surg Oncol
; 129(7): 1348-1353, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38606531
20.
Identifying low cancer-specific mortality risk lymph node-positive radical prostatectomy patients.
J Surg Oncol
; 129(7): 1305-1310, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470523